Jasper Therapeutics Presents Data Supporting Ongoing Development of Briquilimab, its…
<!-- Name:DistributionId Value:8751468 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Briquilimab
Jasper Therapeutics Announces New Positive Briquilimab Data to be Presented at the…
Three abstracts highlight the safety and efficacy of briquilimab combined with low-toxicity radiation conditioning to achieve full donor engraftment and leukemia disease eradication Data…
Jasper Therapeutics Announces European Union Orphan Drug Designation for Briquilimab…
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on transforming the field of hematopoietic cell…